{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:04:18Z","timestamp":1761393858074,"version":"3.37.0"},"reference-count":21,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T00:00:00Z","timestamp":1259020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold>Our primary aim in this study was to determine whether electrically induced activation of the injected muscle increases effectiveness of botulinum type A toxin (BonT\u2010A) in patients with blepharospasm (BPS). The second aim was to assess the safety of BonT\u2010A by investigating whether BonT\u2010A injection alters the excitability of blink reflex circuits in the brainstem.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold>Twenty\u2010three patients with BPS received BonT\u2010A (Botox) injected bilaterally into the orbicularis oculi muscle at a standard dose. In 18 patients, electrically induced muscle activation of the orbicularis oculi muscle on one side was performed for 60\u2003min (4\u2003Hz frequency) in a single session, immediately after BonT\u2010A injection and in five patients for 60\u2003min once a day for five consecutive days. The severity of BPS was assessed clinically with the BPS score. Compound muscle action potential (cMAPs) from the orbicularis oculi muscles were measured bilaterally. The blink reflex recovery cycle was studied at interstimulus intervals of 250 and 500\u2003ms. Participants underwent clinical and neurophysiological assessment before BonT\u2010A injection (T0) and 2\u2003weeks thereafter (T1).<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>Compound muscle action potential amplitude significantly decreased at T1 but did not differ between stimulated and non\u2010stimulated orbicularis oculi in the two groups. BonT\u2010A injection left the blink reflex recovery cycle tested on the stimulated and non\u2010stimulated sides unchanged.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold>In patients with BPS, the electrically induced muscle activation neither increases the effectiveness of BonT\u2010A nor produces larger electrophysiological peripheral effects. The lack of BonT\u2010A\u2010induced changes in the blink reflex recovery cycle provides evidence that BonT\u2010A therapy is safe in patients with BPS.<\/jats:p>","DOI":"10.1111\/j.1468-1331.2009.02840.x","type":"journal-article","created":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T07:45:44Z","timestamp":1259048744000},"page":"449-455","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm"],"prefix":"10.1111","volume":"17","author":[{"given":"A.","family":"Conte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Fabbrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Belvisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Marsili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Di Stasio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Berardelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,2,23]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1962.sp006843"},{"key":"e_1_2_5_3_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3565(25)31908-7","article-title":"Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction","volume":"212","author":"Simpson LL","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(84)90086-7"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.103.2.535"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162203000380"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1123654"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(199903)14:2<307::AID-MDS1016>3.0.CO;2-3"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120115"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)12124-9"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20395"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.54.4.310"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0375-08.2008"},{"key":"e_1_2_5_14_2","first-page":"183","volume-title":"Treatment of Movement Disorders","author":"Brin MF","year":"1995"},{"key":"e_1_2_5_15_2","first-page":"547","article-title":"Electrical stimulation as a therapeutic option to improve eyelid function in chronic facial nerve disorders","volume":"40","author":"Gittins J","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_16_2","first-page":"71","article-title":"Heterogeneous length and in\u2010series arrangement of orbicularis oculi muscle: individual myofibers do not extend the length of the eyelid","volume":"92","author":"Wirtschafter JD","year":"1994","journal-title":"Trans Am Ophthalmol Soc"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2008.49.4.545"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20011"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000345010.98495.fc"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.6.797"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/108.3.593"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870110107"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2009.02840.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1331.2009.02840.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T11:28:38Z","timestamp":1739446118000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2009.02840.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,23]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1468-1331.2009.02840.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02840.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"type":"print","value":"1351-5101"},{"type":"electronic","value":"1468-1331"}],"subject":[],"published":{"date-parts":[[2010,2,23]]},"assertion":[{"value":"2010-02-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}